HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £54.15m
- £56.57m
REG - Hemogenyx Pharma Plc - CBR Intranasal Delivery
AnnouncementREG - Hemogenyx Pharma Plc - FDA Consents to Phase I Trials of HEMO-CAR-T
AnnouncementREG - Hemogenyx Pharma Plc - Approval and Issuance of U.S. Conditioning Patent
AnnouncementREG - Hemogenyx Pharma Plc - Submission of Complete Response to Clinical Hold
AnnouncementREG - Hemogenyx Pharma Plc - HEMO-CAR-T Process Qualification Run Completed
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 04/12/2023
AnnouncementREG - Hemogenyx Pharma Plc - Placing to Raise £534,375
AnnouncementREG - Hemogenyx Pharma Plc - CBR Expanded to Treatment of Cancer
AnnouncementREG - Hemogenyx Pharma Plc - Lentivirus Re-manufacturing Completed
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 05/10/2023
AnnouncementREG - Hemogenyx Pharma Plc - Half-year Report
AnnouncementREG - Hemogenyx Pharma Plc - Strategic Investment from Prevail Partners, LLC
AnnouncementREG - Hemogenyx Pharma Plc - Clinical Hold Lift Plan is accepted by FDA
AnnouncementRCS - Hemogenyx Pharma Plc - CBR Patent Application Update
AnnouncementREG - Hemogenyx Pharma Plc - Full FDA Review for HEMO-CAR-T IND
AnnouncementREG - Hemogenyx Pharma Plc - Result of Annual General Meeting
Announcement